版本:
中国

BRIEF-Immunovaccine's DPX-Survivac gets orphan drug designation by European medicines agency

Nov 22 Immunovaccine Inc :

* The european medicines agency grants orphan drug designation status to Immunovaccine's DPX-Survivac in ovarian cancer Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐